IRulya Therapeutics IRLA
NASDAQ IRLA
$33.78 +2.78 (+8.95%)
At close: Nov 9, 2026 · 4:00 PM EST

IRulya Therapeutics (IRLA) Cash & Current Investments (2018 - 2026)

Updated

IRulya Therapeutics' Cash & Current Investments was $116 million in Q2 2026, up 234.2% from $34.71 million a year earlier and up 537.4% from the prior quarter.

Analysis

IRulya Therapeutics (IRLA) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at IRulya Therapeutics came in at $17.75 million, down 56.5% from FY2024.

  • Cash & Current Investments has now declined for five consecutive years, with a five-year compound annual growth rate of -33.2% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $40.78 million in FY2024 (-45.7%), $75.06 million in FY2023 (-16.8%), $90.18 million in FY2022 (-15.6%) and $106.8 million in FY2021 (-20.2%).
  • The Q2 2026 figure marks the highest quarterly Cash & Current Investments since Q2 2021.
  • Compared with a year earlier, Cash & Current Investments was higher in 1 of the last eight quarters, with an average decline of 11.6%.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q2 2026 (growth of 234.2%); the worst was Q4 2025 (a decline of 56.5%).
  • Per Business Quant data, IRLA's Cash & Current Investments in the three quarters before Q2 2026 was $18.2 million (Q1 2026), $17.75 million (Q4 2025) and $26.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 17.23 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 10.77 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn - 505.00 Mn
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 6.44 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 14.27 Bn
10 IRulya Therapeutics 207.35 Mn 91.35 Mn - 116.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 116.00 Mn
Mar 31, 2026 18.20 Mn
Dec 31, 2025 17.75 Mn
Sep 30, 2025 26.29 Mn
Jun 30, 2025 34.71 Mn
Mar 31, 2025 31.60 Mn
Dec 31, 2024 40.78 Mn
Sep 30, 2024 47.85 Mn
Jun 30, 2024 59.45 Mn
Mar 31, 2024 67.82 Mn
Dec 31, 2023 75.06 Mn
Sep 30, 2023 83.23 Mn
Jun 30, 2023 87.57 Mn
Mar 31, 2023 90.20 Mn
Dec 31, 2022 90.18 Mn
Sep 30, 2022 94.34 Mn
Jun 30, 2022 94.66 Mn
Mar 31, 2022 91.52 Mn
Dec 31, 2021 106.80 Mn
Sep 30, 2021 114.41 Mn
API Access

IRulya Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IRLA&period=max&api_key=YOUR_API_KEY